In August 2015 the Federal Economic Competition Commission (COFECE) approved a concentration
between Dutch fund Moench Coöperatif, UA and one of the major pharmaceutical product
distributors in Mexico, Marzam, through which the former acquired control over the latter. The
concentration was approved without commitments, as the COFECE was advised that Moench
Coöperatif did not participate in the same market as Marzam and thus that there was no overlap
between the agents involved.